The wife of a man whose stress headaches turned out to be cancer has revealed that “lifeline” treatment was taken away from him because of one mistake.
Robin Elcock, 37, lost his life in January 2025 after a gruelling battle with a grade four brain tumour.
The former farmer had gotten the 7cm mass removed and was told to continue on with life as normal, undergoing chemotherapy and routine scans for monitoring.
He, along with his wife, Aimee, 36, and their three kids, Katie, 17, George, 15 and Arthur, nine, then suffered another devastating blow.
It had returned – this time with a vengeance – and so they sought out alternative treatment costing £200,000 to help extend their time together.
The pioneering immunotherapy uses a patient’ own tumour tissue to create a personalised vaccine.
Sadly, the procedure wasn’t able to happen, though, as there was a serious mistake made.
“It felt like a lifeline had been taken from us in an instant,” Aimee, from Gloucestershire, told Need To Know.
“I was shocked and angry when I found out the 7cm of brain tissue removed during Robin’s first surgery hadn’t been stored in a way that made DC vax treatment possible.
“Only a small fragment from the second surgery, just 2cm, had been frozen.
“We were devastated when the doctor in London told us there wasn’t enough tissue to begin treatment here in the UK.
“If we’d been told at the start how important tumour storage was, we could have made an informed choice.
“That knowledge might have given Robin more time.
“No family should have to find out too late that an option is closed to them simply because of a storage decision they weren’t aware of.
“And nor should they have to seek treatment elsewhere, especially outside of the UK.”
Aimee, who was fearful of bringing up their children alone, recalls finding out her husband’s case was terminal.
She said: “When they told us the second tumour was more serious, it was like having the air knocked out of me.
“We’d been through so much already and I’d convinced myself we could keep it at bay.
“But hearing it was now high grade; it felt like the ground shifted beneath us.
“The doctor strangely asked the ages of our children and said Robin would at least live to see our eldest grow up.
“We looked at each other, horrified.
“That was when we realised this was terminal.
“It felt surreal, we were shocked into silence.
“We were so naive and thought they got all the initial tumour out, [so] all it would take is treatment and recovery and we would carry on with the rest of our lives.
“We were gravely wrong.
“I knew Robin understood exactly what it meant, that day, it hit me that our time together might be much shorter than we’d imagined.
“I could see Robin was declining, so out of desperation we sought alternative treatment.”
As Robin wasn’t able to go through the hoped for treatment in the UK, he had to travel to Germany and pay for a new form of treatment.
It uses the immune system to recognise and attack abnormal cells, costing £15,000 per session.
After three trips, there were signs of improvement, until July 2024, when his health sharply declined.
He passed away in January 2025 surrounded by his family and loved ones.
Before he died, he bought a dog for the family, called Aida, which has helped the family deal with their loss.
In May, she and Aida walked Brain Tumour Research’s 200k in his memory.
She hopes to raise awareness with Robin’s battle with the aim that it’ll help give other people suffering with brain tumours a chance at life-saving treatment.
She added: “Brain cancer took his independence, his livelihood, and his ability to do the simplest things, but never his spirit.
“Don’t wait until a brain tumour affects you to find out your choices.
“I want people to know that tumour tissue storage matters.
“If we’d known from day one how vital that was, maybe things could have been different.
“And if sharing our story means one more person gets a chance at a treatment that could save or extend their life, then his fight won’t have been in vain.”
Letty Greenfield, Community Development Manager at Brain Tumour Research, said: “Robin’s story is a stark reminder that patients and families must be given all the facts about tumour tissue storage from day one.
“The ability to access certain treatments in the future can depend entirely on decisions made at the point of surgery.
“We urgently need a consistent, nationwide approach so that no one misses out on potential life-extending therapies because of a lack of information.”
